T. Rowe Price Associates’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $11.2M | Buy |
|
|||||
|
2015
Q3 | $13.7M | Sell |
|
|||||
|
2015
Q2 | $32.6M | Sell |
|
|||||
|
2015
Q1 | $51.8M | Sell |
|
|||||
|
2014
Q4 | $40.4M | Sell |
|
|||||
|
2014
Q3 | $34.7M | Buy |
|
|||||
|
2014
Q2 | $29.6M | Buy |
|
|||||
|
2014
Q1 | $17.1M | Buy |
|
|||||
|
2013
Q4 | $251K | Buy |
|
|||||
|
2013
Q3 | $91K | Sell |
|
|||||
|
2013
Q2 | $5.06M | Buy |
|